NCT06334406View on ClinicalTrials.gov

Antitumor T Cell Responses in Patients With Bladder Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

April 2, 2026

Study Completion Date

April 2, 2026

Conditions
Bladder Cancer
Interventions
OTHER

Biological samples

"Blood samples will be collected at baseline, after the diagnostic TURBT, and D15 after the end of treatment in each cohort.~Tumor tissues will be collected at baseline for three patients."

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT06334406 - Antitumor T Cell Responses in Patients With Bladder Cancer | Biotech Hunter | Biotech Hunter